{
  "metadata": {
    "version": "2.0",
    "lastUpdated": "2025-01-16",
    "maintainer": "Geneva Daniel, Senior Data Scientist, Office of Clinical Research Informatics",
    "contacts": {
      "IRB": {
        "email": "irb@ouhsc.edu",
        "phone": "405-271-2045",
        "location": "O'Donoghue Research Building, Suite CB202",
        "address": "1122 NE 13th Street, Suite CB202, OKC, OK 73117"
      },
      "ORA": {
        "phone": "405-271-2090",
        "fax": "405-271-8651",
        "location": "865 Research Parkway, URP865-450",
        "address": "865 Research Parkway, URP865-450, Oklahoma City, OK 73104-3609"
      },
      "Cancer_Center_PRMC": {
        "email": "scc-prmc@ouhsc.edu",
        "link": "https://www.ouhealth.com/stephenson-cancer-center/cancer-research/cancer-shared-resources-services/protocol-review-monitoring/"
      },
      "Clinical_Research_Informatics": {
        "link": "https://research.ouhsc.edu/epic-for-research"
      },
      "OnCore_Support": {
        "link": "https://research.ouhsc.edu/research-support/office-of-clinical-research-informatics/research-clinical-informatics-resources/oncore-clinical-trials-management-system-ctms"
      },
      "IBC": {
        "email": "ibc@ouhsc.edu"
      },
      "CRIOC": {
        "link": "https://research.ouhsc.edu/crioc",
        "note": "Clinical Research Informatics Operations Committee"
      },
      "OCRI_Resources": {
        "link": "https://research.ouhsc.edu/ocri-resources",
        "note": "Office of Clinical Research Informatics Tools and Resources"
      },
      "REDCap": {
        "link": "https://redcap.ouhsc.edu/",
        "note": "Research Electronic Data Capture - Secure data collection and management"
      },
      "BERD": {
        "link": "https://osctr.ouhsc.edu/",
        "note": "Biostatistics, Epidemiology, and Research Design support through OSCTR"
      },
      "BBMC": {
        "link": "https://ouhsc.edu/bbmc/",
        "note": "Biomedical and Behavioral Methodology Core - Specialized biostatistics support for pediatric research"
      },
      "Clinical_Research_Data_Warehouse": {
        "link": "https://research.ouhsc.edu/ocri-resources",
        "note": "Feasibility assessment, participant identification, and outcome tracking"
      },
      "OSCTR": {
        "link": "https://osctr.ouhsc.edu/",
        "note": "Oklahoma Clinical and Translational Science Institute"
      }
    },
    "timelinePhases": [
      {
        "id": 0,
        "name": "Training, Feasibility & Planning",
        "icon": "graduation-cap",
        "note": "Can begin immediately, in parallel with all other phases. Complete feasibility assessments before any submissions."
      },
      {
        "id": 1,
        "name": "Pre-Submission Reviews",
        "icon": "clipboard-check",
        "note": "Committee reviews required before IRB submission"
      },
      {
        "id": 2,
        "name": "Regulatory Submissions",
        "icon": "file-text",
        "parallel": true,
        "note": "IRB and ORA submissions can proceed concurrently. IRB may request funding details from ORA; ORA may need the IRB protocol number."
      },
      {
        "id": 3,
        "name": "Post-Approval & Study Startup",
        "icon": "rocket",
        "note": "Activities after receiving IRB approval"
      }
    ]
  },
  "questions": [
    {
      "id": "q1_determination",
      "text": "Does your project count as human subjects research?",
      "type": "boolean",
      "helpText": "Human subjects research is defined as a systematic investigation designed to develop or contribute to generalizable knowledge that involves interaction or intervention with living individuals or obtaining identifiable private information.",
      "options": ["I'm unsure", "Yes, this is human subjects research"],
      "checklistItems": {
        "I'm unsure": [
          {
            "text": "Submit Determination of Human Research Worksheet via iRIS",
            "priority": "REQUIRED",
            "order": 1,
            "link": "https://compliance.ouhsc.edu/Offices/Human-Research-Participant-Protection/Norman-Campus-Institutional-Review-Board/How-To-Instructional-Guide/Determination-of-Human-Research-Worksheet",
            "contact": "IRB Office: irb@ouhsc.edu | 405-271-2045",
            "timeline": "Allow 5-7 business days for determination",
            "note": "The IRB will review your submission and determine if it meets the definition of human subjects research. You will receive notification via iRIS with next steps.",
            "phase": 2,
            "track": "A",
            "duration": "5-7 business days"
          }
        ]
      },
      "routing": {
        "I'm unsure": "end_determination",
        "Yes, this is human subjects research": "q2_cancer"
      }
    },
    {
      "id": "q2_cancer",
      "text": "Does your study involve cancer patients, cancer survivors, or cancer-related outcomes?",
      "type": "boolean",
      "helpText": "This includes studies with cancer as the primary diagnosis, cancer treatment studies, cancer prevention studies, cancer survivorship studies, or any study where the primary target population has or had cancer.",
      "options": ["Yes", "No"],
      "checklistItems": {
        "Yes": [
          {
            "text": "Stephenson Cancer Center Protocol Review and Approval",
            "priority": "REQUIRED BEFORE IRB",
            "order": 1,
            "link": "https://www.ouhealth.com/stephenson-cancer-center/cancer-research/cancer-shared-resources-services/protocol-review-monitoring/",
            "contact": "scc-prmc@ouhsc.edu",
            "timeline": "Submit 3-4 months before intended study start; allow 2-3 months total for all cancer center reviews",
            "note": "Cancer-related studies must complete the following sequential reviews before IRB submission. IRB approval cannot be granted without PRMC approval.",
            "details": [
              "Disease Site Group Review: Assesses applicability to patient populations, identifies competing trials, and ensures alignment with Disease Group goals",
              "Feasibility Review Committee (FRC): Evaluates operational complexities, resource utilization, operational feasibility, and cost allocation",
              "Protocol Review and Monitoring Committee (PRMC): Reviews scientific merit, statistical validity, design feasibility, inclusion of underrepresented populations, and study prioritization"
            ],
            "phase": 1,
            "track": "A",
            "duration": "8-12 weeks"
          }
        ]
      },
      "routing": {
        "Yes": "q3_study_type",
        "No": "q3_study_type"
      }
    },
    {
      "id": "q3_study_type",
      "text": "What type(s) of study is this? (Select all that apply)",
      "type": "checkbox",
      "helpText": "Many studies span multiple categories. For example, a study may involve both retrospective chart review and prospective biospecimen collection. Select all that apply to ensure you receive guidance for every component.",
      "options": [
        "Retrospective chart review / data analysis",
        "Prospective interventional (drug, device, procedure, behavioral intervention)",
        "Prospective observational (surveys, interviews, focus groups)",
        "Biospecimen collection and/or analysis",
        "Quality improvement project",
        "Other / Not sure"
      ],
      "routing": {
        "Retrospective chart review / data analysis": "q4_retro_phi",
        "Prospective interventional (drug, device, procedure, behavioral intervention)": "q5_intervention",
        "Prospective observational (surveys, interviews, focus groups)": "q6_observational",
        "Biospecimen collection and/or analysis": "q6_biospecimen",
        "Quality improvement project": "q_qi",
        "Other / Not sure": "q_contact_irb"
      }
    },
    {
      "id": "q4_retro_phi",
      "text": "Will you be accessing or using identifiable patient data (PHI)?",
      "type": "boolean",
      "helpText": "Protected Health Information (PHI) includes: names, dates (except year), phone numbers, email addresses, medical record numbers (MRNs), account numbers, IP addresses, biometric identifiers, full face photos, or any other unique identifying information per HIPAA.",
      "options": ["Yes", "No"],
      "checklistItems": {
        "Yes": [
          {
            "text": "IRB Submission - Full Protocol Required",
            "priority": "REQUIRED",
            "order": 1,
            "link": "https://compliance.ouhsc.edu/HRPP/HSC-IRB",
            "contact": "IRB Office: irb@ouhsc.edu | 405-271-2045",
            "timeline": "Expedited review: 2-3 weeks | Full Board: 4-6 weeks from complete submission",
            "details": [
              "Complete protocol document describing study aims, methods, and data analysis plan",
              "HIPAA waiver or authorization form",
              "Data security and confidentiality plan",
              "Complete personnel list with roles and responsibilities",
              "Data collection instruments/forms"
            ],
            "phase": 2,
            "track": "A",
            "duration": "Expedited: 2-3 weeks | Full Board: 4-6 weeks"
          },
          {
            "text": "All Personnel: Complete CITI Human Subjects Research Training",
            "priority": "REQUIRED",
            "order": 2,
            "link": "https://about.citiprogram.org/",
            "note": "Use your @ouhsc.edu email address to register. Required modules include Basic Course or Refresher Course.",
            "timeline": "Must be completed before IRB submission",
            "phase": 0,
            "track": "A",
            "duration": "4-8 hours, valid 3 years"
          },
          {
            "text": "All Personnel: Complete In-House IRB Training",
            "priority": "REQUIRED",
            "order": 3,
            "contact": "IRB Office: irb@ouhsc.edu",
            "note": "Contact the IRB office to schedule in-house training for all study personnel.",
            "phase": 0,
            "track": "A",
            "duration": "Schedule with IRB"
          },
          {
            "text": "HIPAA Compliance Training",
            "priority": "REQUIRED",
            "order": 4,
            "link": "https://compliance.ouhsc.edu/HIPAA",
            "note": "All personnel accessing PHI must complete HIPAA training.",
            "phase": 0,
            "track": "A",
            "duration": "1-2 hours"
          }
        ],
        "No": [
          {
            "text": "IRB Submission - May Qualify as EXEMPT",
            "priority": "REQUIRED",
            "order": 1,
            "link": "https://compliance.ouhsc.edu/HRPP/HSC-IRB",
            "contact": "IRB Office: irb@ouhsc.edu | 405-271-2045",
            "timeline": "Exempt determination: 1-2 weeks from complete submission",
            "note": "Final determination of exempt status is made by the IRB, not the investigator. Submit via iRIS.",
            "details": [
              "Brief protocol description",
              "Description of data sources",
              "Data handling and security procedures",
              "Personnel list"
            ],
            "phase": 2,
            "track": "A",
            "duration": "Exempt: 1-2 weeks"
          },
          {
            "text": "All Personnel: Complete CITI Human Subjects Research Training",
            "priority": "REQUIRED",
            "order": 2,
            "link": "https://about.citiprogram.org/",
            "note": "Use your @ouhsc.edu email address",
            "phase": 0,
            "track": "A",
            "duration": "4-8 hours, valid 3 years"
          }
        ]
      },
      "routing": {
        "Yes": "q7_funding",
        "No": "q7_funding"
      }
    },
    {
      "id": "q5_intervention",
      "text": "Does your study involve an investigational drug, biologic, or device?",
      "type": "boolean",
      "helpText": "This includes: (1) drugs/biologics not FDA-approved for marketing, (2) FDA-approved drugs/biologics used for non-approved indications, dosages, formulations, or populations, (3) investigational medical devices, or (4) drugs obtained under an IND from another sponsor.",
      "options": ["Yes", "No"],
      "checklistItems": {
        "Yes": [
          {
            "text": "Determine if IND/IDE is Required",
            "priority": "CRITICAL",
            "order": 1,
            "note": "Consult with IRB or contact FDA to determine if an Investigational New Drug (IND) or Investigational Device Exemption (IDE) application is required. You may be designated as the Sponsor-Investigator. Note: All IND/IDE studies are required to be set up in OnCore CTMS.",
            "contact": "IRB Office: irb@ouhsc.edu | 405-271-2045",
            "timeline": "Allow 3-6 months for IND/IDE preparation and FDA review",
            "details": [
              "If IND required: Submit IND application to FDA (Form 1571)",
              "Complete FDA Form 1572 (Investigator Statement) for each site investigator",
              "Maintain current Investigator's Brochure",
              "Establish drug accountability system",
              "Coordinate with investigational pharmacy",
              "Submit annual reports to FDA",
              "IND safety reporting: 7 calendar days for fatal/life-threatening events, 15 calendar days for serious unexpected adverse events",
              "Good Clinical Practice (GCP) training required for all clinical trial personnel"
            ],
            "phase": 1,
            "track": "B",
            "duration": "3-6 months"
          },
          {
            "text": "Investigational Pharmacy Coordination",
            "priority": "REQUIRED",
            "order": 2,
            "note": "Contact investigational pharmacy early in protocol development for drug storage, handling, and dispensing requirements.",
            "phase": 1,
            "track": "F",
            "duration": "Concurrent with IND"
          },
          {
            "text": "IRB Submission - Full Board Review Required",
            "priority": "REQUIRED",
            "order": 3,
            "link": "https://compliance.ouhsc.edu/HRPP/HSC-IRB",
            "timeline": "Full Board review: 4-6 weeks from complete submission; meetings held monthly",
            "details": [
              "Complete protocol with drug/device information",
              "Informed consent form with all required elements",
              "Investigator's Brochure or device manual",
              "IND or IDE approval documentation (if applicable)",
              "Drug/device information and safety data"
            ],
            "phase": 2,
            "track": "A",
            "duration": "Full Board: 4-6 weeks"
          }
        ],
        "No": [
          {
            "text": "IRB Submission Required",
            "priority": "REQUIRED",
            "order": 1,
            "link": "https://compliance.ouhsc.edu/HRPP/HSC-IRB",
            "note": "May qualify for Expedited review if risk is minimal. Full Board review required if greater than minimal risk.",
            "timeline": "Expedited: 2-3 weeks | Full Board: 4-6 weeks",
            "phase": 2,
            "track": "A",
            "duration": "Expedited: 2-3 weeks | Full Board: 4-6 weeks"
          }
        ]
      },
      "routing": {
        "Yes": "q6_additional_approvals",
        "No": "q6_additional_approvals"
      }
    },
    {
      "id": "q6_observational",
      "text": "Does your observational study involve any of the following? (Select all that apply)",
      "type": "checkbox",
      "options": [
        "Vulnerable populations (children, prisoners, pregnant women, decisionally impaired)",
        "Audio or video recording of participants",
        "Collection of sensitive information (illegal activities, sexual behavior, substance use)",
        "None of the above"
      ],
      "checklistItems": {
        "Vulnerable populations (children, prisoners, pregnant women, decisionally impaired)": [
          {
            "text": "Additional IRB Review for Vulnerable Populations",
            "priority": "REQUIRED",
            "order": 1,
            "note": "Studies involving vulnerable populations require additional protections and may require Full Board review.",
            "details": [
              "Assent procedures for children (if applicable)",
              "Parental permission for minors",
              "Pregnancy testing requirements (if applicable)",
              "Additional safeguards documentation"
            ],
            "phase": 2,
            "track": "A",
            "duration": "Included in IRB review"
          }
        ],
        "Audio or video recording of participants": [
          {
            "text": "Audio/Video Recording Consent",
            "priority": "REQUIRED",
            "order": 1,
            "note": "Informed consent must include specific language about recording, how recordings will be used, stored, and destroyed.",
            "details": [
              "Storage and security plan for recordings",
              "Transcription procedures (if applicable)",
              "Destruction timeline",
              "Who will have access to recordings"
            ],
            "phase": 2,
            "track": "A",
            "duration": "Included in consent process"
          }
        ],
        "Collection of sensitive information (illegal activities, sexual behavior, substance use)": [
          {
            "text": "Certificate of Confidentiality",
            "priority": "RECOMMENDED",
            "order": 1,
            "note": "Consider obtaining a Certificate of Confidentiality from NIH to protect against forced disclosure of identifiable research information.",
            "link": "https://grants.nih.gov/policy/humansubjects/coc.htm",
            "phase": 2,
            "track": "A",
            "duration": "Apply during IRB submission"
          }
        ]
      },
      "routing": "q6_additional_approvals"
    },
    {
      "id": "q6_biospecimen",
      "text": "Will you be collecting NEW biospecimens from participants?",
      "type": "boolean",
      "helpText": "Select 'Yes' if you will be obtaining blood, tissue, saliva, urine, or any other biological samples FROM participants as part of this study. Select 'No' if you are only analyzing existing stored specimens.",
      "options": ["Yes", "No"],
      "checklistItems": {
        "Yes": [
          {
            "text": "Biospecimen Collection and Storage Plan",
            "priority": "REQUIRED IN PROTOCOL",
            "order": 1,
            "details": [
              "Collection procedures and volumes",
              "Storage location and conditions",
              "Specimen tracking system",
              "Future use plans (if any)",
              "Destruction timeline",
              "Banking procedures (if applicable)"
            ],
            "phase": 2,
            "track": "A",
            "duration": "Include in protocol"
          },
          {
            "text": "IRB Submission",
            "priority": "REQUIRED",
            "order": 2,
            "note": "Biospecimen collection typically qualifies for Expedited review if minimal risk and no more than minimal discomfort.",
            "phase": 2,
            "track": "A",
            "duration": "Expedited: 2-3 weeks"
          }
        ],
        "No": [
          {
            "text": "IRB Submission - Existing Specimen Analysis",
            "priority": "REQUIRED",
            "order": 1,
            "note": "May qualify for Exempt review if specimens are de-identified or analyzed as part of existing approved study.",
            "phase": 2,
            "track": "A",
            "duration": "Exempt: 1-2 weeks"
          }
        ]
      },
      "routing": "q6_additional_approvals"
    },
    {
      "id": "q6_additional_approvals",
      "text": "Does your study involve any of the following? (Select all that apply)",
      "type": "checkbox",
      "options": [
        "Radiation or radioactive materials",
        "Recombinant DNA, infectious agents, toxins, or other biohazards",
        "Recruiting or enrolling patients at the VA Medical Center",
        "None of the above"
      ],
      "checklistItems": {
        "Radiation or radioactive materials": [
          {
            "text": "Radiation Safety Committee Approval",
            "priority": "REQUIRED BEFORE IRB",
            "order": 1,
            "contact": "Radiation Safety Office",
            "timeline": "Submit 2-3 months before IRB submission",
            "note": "Required for any use of radioactive materials, radiation-producing equipment, or procedures involving radiation exposure beyond standard of care.",
            "phase": 1,
            "track": "C",
            "duration": "8-12 weeks"
          }
        ],
        "Recombinant DNA, infectious agents, toxins, or other biohazards": [
          {
            "text": "Institutional Biosafety Committee (IBC) Approval",
            "priority": "REQUIRED BEFORE IRB",
            "order": 1,
            "contact": "ibc@ouhsc.edu",
            "timeline": "Submit 1-2 months before IRB submission",
            "note": "Required for research involving recombinant or synthetic nucleic acids, biohazardous agents, or select agents and toxins.",
            "phase": 1,
            "track": "D",
            "duration": "4-8 weeks"
          }
        ],
        "Recruiting or enrolling patients at the VA Medical Center": [
          {
            "text": "VA Research and Development Committee Approval",
            "priority": "REQUIRED",
            "order": 1,
            "timeline": "Submit 2-3 months in advance of intended enrollment",
            "note": "Separate VA R&D approval is required for any research activities at the Oklahoma City VA Medical Center, even if approved by OUHSC IRB.",
            "phase": 1,
            "track": "E",
            "duration": "8-12 weeks"
          }
        ]
      },
      "routing": "q7_funding"
    },
    {
      "id": "q7_funding",
      "text": "Does your study have external funding?",
      "type": "boolean",
      "helpText": "External funding includes: federal grants (NIH, NSF, DoD, etc.), foundation funding, industry sponsorship, nonprofit organization support, or any other funding source outside of your department or institution. Tip: IRB and ORA submissions can proceed concurrently in most cases. Begin both submissions simultaneously to minimize your total timeline.",
      "options": ["Yes", "No"],
      "checklistItems": {
        "Yes": [
          {
            "text": "Submit Proposal Through Office of Research Administration (ORA)",
            "priority": "REQUIRED BEFORE AWARD ACCEPTANCE",
            "order": 1,
            "contact": "ORA: 405-271-2090 | Fax: 405-271-8651",
            "link": "https://research.ouhsc.edu/ora",
            "location": "865 Research Parkway, URP865-450, Oklahoma City, OK 73104-3609",
            "timeline": "Submit at least 5 business days before sponsor deadline",
            "note": "The institution cannot accept award funding without ORA routing and approval. IRB and ORA submissions can proceed concurrently; ORA requires the grant application, budget, and institutional commitment letters.",
            "details": [
              "Complete budget and budget justification",
              "NIH biosketches for all key personnel (if NIH funding)",
              "Current and pending support for all key personnel",
              "Facilities and resources document",
              "Letters of support/commitment (if applicable)",
              "Institutional commitment letters (if cost-sharing required)"
            ],
            "phase": 2,
            "track": "B",
            "duration": "5 business days before deadline"
          },
          {
            "text": "Obtain ORA Routing and Final Approval",
            "priority": "REQUIRED",
            "order": 2,
            "contact": "ORA: 405-271-2090",
            "note": "All proposals must be routed through ORA for institutional review, approval, and signature. This includes review of budget, compliance requirements, and institutional commitments.",
            "phase": 2,
            "track": "B",
            "duration": "Varies by sponsor"
          },
          {
            "text": "Conflict of Interest Disclosure",
            "priority": "REQUIRED",
            "order": 3,
            "note": "All investigators must disclose financial conflicts of interest related to the research. Required by federal regulation for PHS-funded research.",
            "phase": 2,
            "track": "C",
            "duration": "1-2 weeks"
          }
        ]
      },
      "routing": {
        "Yes": "q8_epic",
        "No": "q8_epic"
      }
    },
    {
      "id": "q8_epic",
      "text": "Will you need Epic EHR integration for your study?",
      "type": "boolean",
      "helpText": "Epic integration may be needed if you require: research-specific order sets, study documentation templates, automated subject identification in patient charts, data collection through Epic forms, or interface with OnCore for subject enrollment.",
      "options": ["Yes", "No"],
      "checklistItems": {
        "Yes": [
          {
            "text": "Contact Clinical Research Informatics Team",
            "priority": "RECOMMENDED",
            "order": 1,
            "link": "https://research.ouhsc.edu/epic-for-research",
            "timeline": "Initiate contact 2-3 months before anticipated study start date",
            "note": "The Clinical Research Informatics team can help with Epic functionality to support your research study.",
            "details": [
              "Research order sets (if needed for standardized procedures)",
              "Research coordinator note templates",
              "Subject identification banner in Epic",
              "OnCore-Epic interface for subject demographics and enrollment",
              "MyChart questionnaires for patient-reported outcomes (if applicable)",
              "Custom Epic reports (if needed)"
            ],
            "phase": 3,
            "track": "B",
            "duration": "2-3 months"
          },
          {
            "text": "Obtain Epic Account and Access Permissions",
            "priority": "REQUIRED",
            "order": 2,
            "note": "Research personnel who need Epic access must have an Epic account with appropriate permissions. Epic account permissions must be submitted by your supervisor (or whoever would be your supervisor in Epic). There are two types of access: full documentation access and read-only access.",
            "details": [
              "Your supervisor/Epic supervisor submits the access request on your behalf",
              "Full Documentation Access: For coordinators who will document in Epic (see Epic Documentation Access Instructions)",
              "Read-Only Access: For personnel who only need to view patient records (see Epic Read-Only Access Instructions)"
            ],
            "phase": 3,
            "track": "B",
            "duration": "Submit early - account setup takes time"
          },
          {
            "text": "Plan for Epic Training",
            "priority": "RECOMMENDED",
            "order": 3,
            "note": "Research coordinators will need Epic training on research-specific functionality and documentation.",
            "phase": 3,
            "track": "B",
            "duration": "Included in Epic setup"
          }
        ]
      },
      "routing": {
        "Yes": "q8b_crioc",
        "No": "q8b_crioc"
      }
    },
    {
      "id": "q8b_crioc",
      "text": "Does your study involve any of the following? (Select all that apply)",
      "type": "checkbox",
      "helpText": "CRIOC (Clinical Research Informatics Operations Committee) review is required for studies that share data outside the university or involve large patient populations. This ensures proper data governance and security.",
      "options": [
        "Sharing data outside of the university (external collaborators, sponsors, registries)",
        "Sample size exceeding 500 patients",
        "None of the above"
      ],
      "checklistItems": {
        "Sharing data outside of the university (external collaborators, sponsors, registries)": [
          {
            "text": "CRIOC Review Required - External Data Sharing",
            "priority": "REQUIRED",
            "order": 1,
            "link": "https://research.ouhsc.edu/crioc",
            "note": "Studies that share data outside the university must be reviewed by the Clinical Research Informatics Operations Committee (CRIOC) to ensure proper data governance, security protocols, and compliance with institutional policies. Submit CRIOC review when your IRB submission is submitted.",
            "timeline": "Submit concurrent with IRB submission",
            "phase": 2,
            "track": "D",
            "duration": "Submit with IRB"
          }
        ],
        "Sample size exceeding 500 patients": [
          {
            "text": "CRIOC Review Required - Large Sample Size",
            "priority": "REQUIRED",
            "order": 1,
            "link": "https://research.ouhsc.edu/crioc",
            "note": "Studies with sample sizes exceeding 500 patients require CRIOC review to assess data infrastructure needs, ensure appropriate resource allocation, and verify data handling procedures. Submit CRIOC review when your IRB submission is submitted.",
            "timeline": "Submit concurrent with IRB submission",
            "phase": 2,
            "track": "D",
            "duration": "Submit with IRB"
          }
        ],
        "None of the above": [
          {
            "text": "Explore OCRI Tools and Resources",
            "priority": "RECOMMENDED",
            "order": 1,
            "link": "https://research.ouhsc.edu/ocri-resources",
            "note": "The Office of Clinical Research Informatics offers various tools and resources that may benefit your study, including data extraction support, REDCap, research data warehousing, and more. Review available resources to see if any could enhance your research.",
            "phase": 3,
            "track": "D",
            "duration": ""
          }
        ]
      },
      "routing": "q9_oncore"
    },
    {
      "id": "q9_oncore",
      "text": "Does your study require OnCore CTMS? (Select all that apply)",
      "type": "checkbox",
      "helpText": "OnCore is required if ANY of the following apply: the study is a clinical trial enrolling subjects, has a billable component, uses MyChart messaging for recruitment, requires subject study status to appear in Epic, or involves an IND or IDE. If none apply, OnCore is still recommended for study management.",
      "options": [
        "Clinical trial enrolling and tracking subjects",
        "Study has a billable component",
        "Using MyChart messaging for recruitment",
        "Subject study status needs to appear in Epic/OnCore",
        "Study involves an IND or IDE",
        "None of the above"
      ],
      "checklistItems": {
        "Clinical trial enrolling and tracking subjects": [
          {
            "text": "Set Up Study in OnCore CTMS",
            "priority": "REQUIRED",
            "order": 1,
            "link": "https://research.ouhsc.edu/research-support/office-of-clinical-research-informatics/research-clinical-informatics-resources/oncore-clinical-trials-management-system-ctms",
            "timeline": "Request access 1-2 months before study activation",
            "note": "REQUIRED per institutional policy effective March 25, 2025. OnCore is OUHSC's designated Clinical Trial Management System (CTMS) for protocol management, subject enrollment, financial tracking, and regulatory compliance.",
            "details": [
              "Protocol setup and calendar",
              "Subject enrollment and consent tracking",
              "Visit scheduling and tracking",
              "Financial management and billing compliance",
              "Biospecimen tracking (if applicable)",
              "Adverse event reporting",
              "Regulatory document management"
            ],
            "phase": 3,
            "track": "A",
            "duration": "1-2 months"
          },
          {
            "text": "Request OnCore Account and Complete Training",
            "priority": "REQUIRED",
            "order": 2,
            "link": "https://research.ouhsc.edu/oncore",
            "note": "New OnCore users must complete the 'Basics of OnCore' curriculum via OnPoint before their account is activated. Training is assigned based on requested roles (Protocol Management, Subject Management, Financials, etc.). Limited access is granted if role-specific trainings beyond basics are not completed. For non-oncology users, submit an OnCore User Account Request via the IT support portal. For oncology users, contact SCCTrainingandSupport@ou.edu. Account creation takes 3-5 business days after training completion.",
            "contact": "General: CTMS-support@ouhsc.edu | Oncology: SCCTrainingandSupport@ou.edu",
            "timeline": "Allow 1-2 weeks for training and account setup",
            "details": [
              "Complete 'Basics of OnCore' curriculum (required for all users)",
              "Request roles: Protocol Manager, Research Coordinator, Financials, etc.",
              "Receive two activation emails: training environment and production environment",
              "Activation links expire after 24 hours - activate promptly",
              "Log in with OUHSC or OU Health credentials"
            ],
            "phase": 3,
            "track": "A",
            "duration": "1-2 weeks for training + account setup"
          },
          {
            "text": "ClinicalTrials.gov Registration",
            "priority": "REQUIRED FOR APPLICABLE TRIALS",
            "order": 3,
            "note": "Required by FDAAA 801 and the Final Rule (42 CFR Part 11) for applicable clinical trials. Results must be reported within 1 year of primary completion date. OnCore can assist with trial registration.",
            "link": "https://clinicaltrials.gov/",
            "phase": 3,
            "track": "A",
            "duration": "Registration within 21 days of first enrollment; results within 1 year of completion"
          }
        ],
        "Study has a billable component": [
          {
            "text": "OnCore CTMS Required - Billable Study",
            "priority": "REQUIRED",
            "order": 1,
            "link": "https://research.ouhsc.edu/research-support/office-of-clinical-research-informatics/research-clinical-informatics-resources/oncore-clinical-trials-management-system-ctms",
            "note": "Studies with billable components must be set up in OnCore for financial management, billing compliance, and coverage analysis.",
            "phase": 3,
            "track": "A",
            "duration": "1-2 months"
          }
        ],
        "Using MyChart messaging for recruitment": [
          {
            "text": "OnCore CTMS Required - MyChart Recruitment",
            "priority": "REQUIRED",
            "order": 1,
            "note": "Studies using MyChart messaging for participant recruitment must be registered in OnCore to enable the MyChart-OnCore integration.",
            "phase": 3,
            "track": "A",
            "duration": "1-2 months"
          }
        ],
        "Subject study status needs to appear in Epic/OnCore": [
          {
            "text": "OnCore CTMS Required - Subject Study Status in Epic",
            "priority": "REQUIRED",
            "order": 1,
            "note": "If subject study enrollment status needs to appear in Epic (e.g., research subject banner), the study must be configured in OnCore with the OnCore-Epic interface.",
            "phase": 3,
            "track": "A",
            "duration": "1-2 months"
          }
        ],
        "Study involves an IND or IDE": [
          {
            "text": "OnCore CTMS Required - IND/IDE Study",
            "priority": "REQUIRED",
            "order": 1,
            "note": "All studies operating under an Investigational New Drug (IND) or Investigational Device Exemption (IDE) are required to be set up in OnCore for regulatory compliance and subject tracking.",
            "phase": 3,
            "track": "A",
            "duration": "1-2 months"
          }
        ],
        "None of the above": [
          {
            "text": "Consider OnCore for Study Management",
            "priority": "RECOMMENDED",
            "order": 1,
            "note": "OnCore can be used for observational studies and registries to track participants, manage visits, and store study documents. Contact OnCore support to discuss if beneficial for your study.",
            "phase": 3,
            "track": "A",
            "duration": ""
          }
        ]
      },
      "routing": "q9b_oncore_setup"
    },
    {
      "id": "q9b_oncore_setup",
      "text": "Is OU Health Campus the IRB board of record for this study?",
      "type": "boolean",
      "helpText": "If OUHSC IRB is the reviewing IRB (board of record), your iRIS submission can be automatically linked to OnCore. If another institution's IRB is the board of record (e.g., via a reliance agreement), you will need to create your OnCore protocol manually.",
      "options": ["Yes", "No"],
      "checklistItems": {
        "Yes": [
          {
            "text": "Complete iRIS-to-OnCore Questionnaire",
            "priority": "REQUIRED",
            "order": 1,
            "link": "https://redcap.link/iris2oncore",
            "note": "Since OU Health Campus is the IRB of record, complete this REDCap questionnaire to automatically create your OnCore protocol from your iRIS submission. This streamlines protocol setup and avoids duplicate data entry.",
            "timeline": "Complete after IRB submission is in iRIS",
            "phase": 3,
            "track": "A",
            "duration": "Complete after iRIS submission"
          },
          {
            "text": "OnCore Calendar and Coverage Analysis",
            "priority": "REQUIRED",
            "order": 2,
            "note": "Once your OnCore protocol is created, work with your OnCore support contact to build the study calendar and complete coverage analysis (if applicable). For non-oncology studies, contact Geneva-Daniel@ou.edu. For oncology studies, contact SCCTrainingandSupport@ou.edu.",
            "contact": "Non-oncology: Geneva-Daniel@ou.edu | Oncology: SCCTrainingandSupport@ou.edu",
            "phase": 3,
            "track": "A",
            "duration": "Concurrent with IRB review"
          },
          {
            "text": "Complete Research Study Activation Questionnaire",
            "priority": "REQUIRED",
            "order": 3,
            "note": "Once your OnCore protocol is correct, has a completed calendar, and coverage analysis (if applicable), complete the Research Study Activation Questionnaire to push the study to Epic. This is required before any study activities can begin in the clinical environment.",
            "timeline": "After OnCore protocol, calendar, and coverage analysis are finalized",
            "phase": 3,
            "track": "A",
            "duration": "After OnCore setup is complete"
          }
        ],
        "No": [
          {
            "text": "Create OnCore Protocol Manually",
            "priority": "REQUIRED",
            "order": 1,
            "note": "Since OU Health Campus is not the IRB of record, you will need to create your OnCore protocol manually rather than using the iRIS-to-OnCore questionnaire. Contact your OnCore support contact for assistance. For non-oncology studies, contact Geneva-Daniel@ou.edu. For oncology studies, contact SCCTrainingandSupport@ou.edu.",
            "contact": "Non-oncology: Geneva-Daniel@ou.edu | Oncology: SCCTrainingandSupport@ou.edu",
            "phase": 3,
            "track": "A",
            "duration": "1-2 months"
          },
          {
            "text": "OnCore Calendar and Coverage Analysis",
            "priority": "REQUIRED",
            "order": 2,
            "note": "Work with your OnCore support contact to build the study calendar and complete coverage analysis (if applicable). For non-oncology studies, contact Geneva-Daniel@ou.edu. For oncology studies, contact SCCTrainingandSupport@ou.edu.",
            "contact": "Non-oncology: Geneva-Daniel@ou.edu | Oncology: SCCTrainingandSupport@ou.edu",
            "phase": 3,
            "track": "A",
            "duration": "Concurrent with IRB review"
          },
          {
            "text": "Complete Research Study Activation Questionnaire",
            "priority": "REQUIRED",
            "order": 3,
            "note": "Once your OnCore protocol is correct, has a completed calendar, and coverage analysis (if applicable), complete the Research Study Activation Questionnaire to push the study to Epic. This is required before any study activities can begin in the clinical environment.",
            "timeline": "After OnCore protocol, calendar, and coverage analysis are finalized",
            "phase": 3,
            "track": "A",
            "duration": "After OnCore setup is complete"
          }
        ]
      },
      "routing": "q10_final"
    },
    {
      "id": "q10_final",
      "text": "Review and finalize your compliance checklist",
      "type": "summary",
      "fixedChecklistItems": [
        {
          "text": "All Study Personnel: Complete CITI Human Subjects Research Training",
          "priority": "REQUIRED",
          "order": 1,
          "link": "https://about.citiprogram.org/",
          "note": "All personnel listed on IRB application must complete appropriate CITI training modules BEFORE IRB submission. Use @ouhsc.edu email to register. Courses include: Basic Course (for new researchers) or Refresher Course (if previously completed).",
          "timeline": "Valid for 3 years",
          "phase": 0,
          "track": "A",
          "duration": "4-8 hours, valid 3 years"
        },
        {
          "text": "All Study Personnel: Complete In-House IRB Training",
          "priority": "REQUIRED",
          "order": 2,
          "contact": "IRB Office: irb@ouhsc.edu | 405-271-2045",
          "note": "In-house IRB training covers OUHSC-specific policies and procedures. Contact IRB office to schedule training for your research team.",
          "phase": 0,
          "track": "A",
          "duration": "Schedule with IRB"
        },
        {
          "text": "Compile Complete IRB Submission Packet",
          "priority": "REQUIRED",
          "order": 3,
          "link": "https://compliance.ouhsc.edu/HRPP/HSC-IRB",
          "note": "Ensure all required documents are complete before submission to avoid delays.",
          "details": [
            "Protocol document with all required sections",
            "Informed consent form(s) with all required elements",
            "HIPAA authorization or waiver justification",
            "Recruitment materials (flyers, scripts, advertisements)",
            "Data collection instruments (surveys, questionnaires, case report forms)",
            "Grant application (if externally funded)",
            "All approval letters from other committees (Cancer Center, IBC, Radiation Safety, etc.)",
            "Investigator's Brochure or device manual (if applicable)",
            "Collaborative agreements or reliance agreements (if multi-site)",
            "Personnel list with roles, qualifications, and training completion"
          ],
          "phase": 2,
          "track": "A",
          "duration": "Compile before submission"
        },
        {
          "text": "Submit Protocol to IRB via iRIS",
          "priority": "REQUIRED",
          "order": 4,
          "link": "https://iris.ouhsc.edu",
          "contact": "IRB Office: irb@ouhsc.edu | 405-271-2045",
          "timeline": "Exempt determination: 1-2 weeks | Expedited review: 2-3 weeks | Full Board review: 4-6 weeks (from complete submission; meetings held monthly)",
          "note": "There is no such thing as retroactive IRB approval. Do not begin any research activities until you receive IRB approval notification.",
          "phase": 2,
          "track": "A",
          "duration": "Exempt: 1-2 wk | Expedited: 2-3 wk | Full Board: 4-6 wk"
        },
        {
          "text": "Respond Promptly to IRB Requests",
          "priority": "REQUIRED",
          "order": 5,
          "note": "If the IRB requests modifications or additional information, respond as quickly as possible. Delays in responding extend the overall approval timeline. Incomplete responses may require additional review cycles.",
          "phase": 2,
          "track": "A",
          "duration": ""
        },
        {
          "text": "Consider REDCap for Data Collection and Management",
          "priority": "RECOMMENDED",
          "order": 10,
          "link": "https://redcap.ouhsc.edu/",
          "note": "REDCap (Research Electronic Data Capture) is a secure, web-based application for building and managing online surveys and research databases. Features include validated data entry, audit trails, automated export to statistical packages, calendar/scheduling modules, and multi-site project access. Plan your REDCap project early so instruments are ready before enrollment begins.",
          "phase": 0,
          "track": "B",
          "duration": "Set up during study planning"
        },
        {
          "text": "Consider BERD or BBMC for Biostatistics and Study Design Support",
          "priority": "RECOMMENDED",
          "order": 11,
          "link": "https://osctr.ouhsc.edu/",
          "note": "The Biostatistics, Epidemiology, and Research Design (BERD) core provides consultation on study design, sample size calculations, statistical analysis plans, and data analysis through OSCTR. For pediatric research, the Biomedical and Behavioral Methodology Core (BBMC, ouhsc.edu/bbmc) offers specialized biostatistics support including power analysis, analytics, and protocol consultation. Engage early in study planning, before submissions.",
          "phase": 0,
          "track": "B",
          "duration": "Engage early in study planning"
        },
        {
          "text": "Consider Clinical Research Data Warehouse for Feasibility Assessment",
          "priority": "RECOMMENDED",
          "order": 12,
          "link": "https://research.ouhsc.edu/ocri-resources",
          "note": "The Clinical Research Data Warehouse can assist with feasibility assessment, potential participant identification, and outcome tracking to support your study planning. Feasibility assessments should be completed prior to submitting your study to IRB or any other review body. Note: Initial consultation is free; additional CRDW services may have associated costs.",
          "phase": 0,
          "track": "B",
          "duration": "Complete before any submissions"
        }
      ],
      "routing": "summary"
    },
    {
      "id": "q_qi",
      "text": "Quality Improvement Project",
      "type": "info",
      "content": "Quality improvement (QI) projects may not require IRB review if they meet specific criteria. However, the distinction between QI and research can be complex.",
      "checklistItems": [
        {
          "text": "Submit Determination of Human Research Worksheet",
          "priority": "RECOMMENDED",
          "order": 1,
          "link": "https://compliance.ouhsc.edu/Offices/Human-Research-Participant-Protection/Norman-Campus-Institutional-Review-Board/How-To-Instructional-Guide/Determination-of-Human-Research-Worksheet",
          "contact": "IRB Office: irb@ouhsc.edu | 405-271-2045",
          "note": "Let the IRB make the determination of whether your QI project constitutes human subjects research. Better to ask than to assume.",
          "phase": 2,
          "track": "A",
          "duration": "5-7 business days"
        }
      ],
      "routing": "end_determination"
    },
    {
      "id": "q_contact_irb",
      "text": "Contact IRB for Guidance",
      "type": "info",
      "content": "Your study doesn't fit the standard categories. We recommend contacting the IRB office for personalized guidance.",
      "checklistItems": [
        {
          "text": "Schedule IRB Consultation",
          "priority": "RECOMMENDED",
          "order": 1,
          "contact": "IRB Office: irb@ouhsc.edu | 405-271-2045",
          "link": "https://compliance.ouhsc.edu/Offices/Human-Research-Participant-Protection/OUHSC-Institutional-Review-Board/Consultation-and-Training-Requests",
          "note": "The IRB offers consultations to help investigators determine requirements for their specific study. This is especially helpful for unusual or complex research designs.",
          "phase": 2,
          "track": "A",
          "duration": "Schedule at earliest convenience"
        }
      ],
      "routing": "end_determination"
    }
  ]
}
